Evidence map›Paper›PMID 30325767›Full record

ArticleAIDS (London, England)2019

Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.

Daniela K van Santen, Jannie J van der Helm, Giota Touloumi, Nikos Pantazis, Roberto Muga, Barbara Gunsenheimer-Bartmeyer, M John Gill, Eduard Sanders, Anthony Kelleher, Robert Zangerle and 4 more

Open access · greenAbstract read
In one paragraph

Article in AIDS (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 10 countries.

Daniela K van SantenDepartment of Infectious Disease Research and Prevention, Public Health Service of Amsterdam, Amsterdam.
Jannie J van der HelmDepartment of Infectious Disease Research and Prevention, Public Health Service of Amsterdam, Amsterdam.
Giota TouloumiDepartment of Hygiene, Epidemiology and Medical Statistics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Nikos PantazisDepartment of Hygiene, Epidemiology and Medical Statistics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Roberto MugaDepartment of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Barbara Gunsenheimer-BartmeyerRobert Koch Institute, Berlin, Germany.
M John GillDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Eduard SandersKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Anthony KelleherKirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Robert ZangerleMedical University of Innsbruck, Innsbruck, Austria.
Kholoud PorterInstitute for Global Health, University College London, London, UK.
Maria PrinsDepartment of Infectious Disease Research and Prevention, Public Health Service of Amsterdam, Amsterdam.
Ronald B GeskusDepartment of Infectious Disease Research and Prevention, Public Health Service of Amsterdam, Amsterdam.
CASCADE Collaboration within EuroCoord
National and Kapodistrian University of Athens · GRGGD Amsterdam · NLInnsbruck Medical University · ATInstitute of Infection and Immunity · CAKenya Medical Research Institute · KENational Institute for Public Health and the Environment · NLRobert Koch Institute · DEUniversitat Autònoma de Barcelona · ESUniversity College London · GBUniversity of Calgary · CAUniversity of Oxford · GBUNSW Sydney · AU

Funding

Medical Research Council MC_U122886351Medical Research Council MC_UU_12023/15Wellcome Trust 203077
6 · The paper itself

Abstract

backgroundMost studies on hepatitis C virus (HCV)/HIV-coinfection do not account for the order and duration of these two infections. We aimed to assess the effect of incident HCV infection, and its timing relative to HIV seroconversion (HIVsc) in HIV-positive MSM on their subsequent CD4+ T-cell count and HIV RNA viral load trajectories.

methodsWe included MSM with well estimated dates of HIVsc from 17 cohorts within the CASCADE Collaboration. HCV-coinfected MSM were matched to as many HIV monoinfected MSM as possible by HIV-infection duration and combination antiretroviral therapy (cART) use. We used multilevel random-effects models stratified by cART use to assess differences in CD4+ cell count and HIV RNA viral load trajectories by HCV-coinfection status.

findingsWe matched 214 (ART-naive) and 147 (on cART) HCV-coinfected MSM to 5384 and 3954, respectively, matched controls. The timing of HCV seroconversion (HCVsc) relative to HIVsc had no demonstrable effect on HIV RNA viral load or CD4+ cell count trajectories. In the first 2-3 years following HCVsc CD4 cell counts were lower among HCV-coinfected MSM, but became comparable with HIV monoinfected MSM thereafter. In ART-naive MSM, during the first 2 years after HCVsc, HIV RNA viral load levels were lower or comparable with HIV monoinfected, tending to be higher thereafter. In MSM on cART, HCV had no significant effect on having a detectable HIV RNA viral load.

interpretationIrrespective of the duration of HIV infection when HCV is acquired, CD4+ cell counts were temporarily lower following HCVsc, even when on cART. The clinical implications of our findings remain to be further elucidated.

Indexed as

Viral LoadAdultCD4 Lymphocyte CountCoinfectionHepatitis CHIV-1HIV InfectionsHomosexuality, MaleHumansMaleMiddle AgedRNA, ViralRNA, Viral

Identifiers

PMID30325767
PMCPMC7116662
OpenAlexW2896073281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.